Cvi Holdings, LLC Replimune Group, Inc. Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$18.85 - $27.0 $3.51 Million - $5.03 Million	-186,187 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $1.25 Million - $3.31 Million	127,592 Added 217.75%	186,187 $4.63 Million
Q1 2020 May 15, 2020	SELL	$8.9 - $19.08 $3.13 Million - $6.71 Million	-351,933 Reduced 85.73%	58,595 $584,000
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $4.77 Million - $7.07 Million	410,528 New	410,528 $5.89 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $605M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.